Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 11, 2018 9:30 AM - Nov 13, 2018 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

15th DIA Japan Annual Meeting 2018

Innovative technologies such as AI, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us to discuss these topics.

[V3-S6] The Near Future of Clinical Operation - ICT Leading Virtual Clinical Trial -

Session Chair(s)

Mitsuo  Hayashi, MSc, RPh

Mitsuo Hayashi, MSc, RPh

Director & Head, Clinical Enablement

MSD K.K., Japan

The progress of ICT is remarkable. We are already in such a world that you can easily measure your vital sign if wearing iWatch and you can get various information quickly if speaking to a smart speaker. Clinical trials have also experienced changes due to ICT innovation. For example, RBM is a way of thinking developed by CRF changing from paper based to electronic one. However clinical trials are areas where it is still possible to make innovative approach using ICT technology. In this session, we will introduce the present situation of Virtual Clinical Trial in EU and US, and the development and challenge of Virtual Clinical Trial in Japan. We would appreciate it if you could create a world where enrollment and site visit will change dramatically by thinking about patient engagement.

Speaker(s)

Jing  Liu, MD

Application of Mobile Health in Clinical Development

Jing Liu, MD

Parexel International Inc., Japan

Corporate VP, Regional Head, Medical Sciences, APAC

Bryan  McDowell, MBA, MSc

Will Decentralized Clinical Trials be the Game-changer for Drug Development? A Deep Dive into the Opportunities, Benefits, and Challenges of Patient-centric Disruptive Trials Models

Bryan McDowell, MBA, MSc

Clario, Switzerland

Vice President, eCOA Clinical Science and Consulting

Makiko  Okamoto

Could Virtual Clinical Trial Lead Transformation for Clinical Trial in Japan? - From the Experience of Home Visit Trial -

Makiko Okamoto

Eli Lilly Japan K.K., Japan

Sr. Manager, Clinical Innovations & Business Integration, Medical Development

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.